Login
http://www.aldaorg.net
Plasma RX Skin Resurfing offered at Lumiere Dermatology

New Delhi, June 29, 2017: Your Path to Clear Skin! In today's competitive life where looks matter more and more, we all want to look amazing. With growing age and hectic life full of stress, many of us experience reduced skin integrity, leading to aging, wrinkles, sagging, acne-scars and sun damaged skin, frown lines, crow's feet, brown spots and stretch marks that often mask our inner beauty. Lumiere Dermatology specialises in continually updating their treatments with the latest, innovative and scientifically most advanced breakthrough technologies, it is easier than ever to reclaim fresh,

“8th National Midterm CME-ISPR 2017” organized in the city

Bangalore, June 29, 2017: Columbia Asia Radiology Group in association with Indian Society of Paediatric Radiology (ISPR) organised the “8th National Midterm CME-ISPR 2017” on 25th June, 2017, Sunday, at Columbia Asia Hospital, Whitefield. The event focused on talks and discussions themed around ‘Paediatric Neuroradiology’. The conference was planned focussing radiologists and was aimed to demonstrate relevant key anatomy, concepts in embryology, unique imaging challenges with solutions to handle and easy systematic approaches. “There werea series of engaging and brain storming ses

Hairline Diagnostics and Healthcare Among World's Greatest Brands 2016-17

Bangalore, June 28, 2017: Hairline Diagnostics and Healthcare was recently named among the World's Greatest Brands 2016-17, in the Health Care Industry, under the category of Hair and Skin Clinics. The award was presented at the third edition of the India-UAE Business & Social Forum 2017 along with World's Greatest Brands and Leaders 2016-17 – Asia and GCC, in Dubai. The research for these awards was done by United Research Services and process reviewers were Price water house Coopers P.L. Speaking on receiving this award, Dr. Bani Anand, Founder and Managing Director, Hairline Diagnost

Infinite ways to relax your body OSIM brings uInfinity Lifestyle Massage chair

New Delhi, June 28, 2017: A veteran in massage products, OSIM brings uInfinity, a lifestyle massage chair that lets you download new programs as per your body. Being the only one-of-its-kind massage chair in the world, it lets you feel that human touch. Its humanized massage programs help you to relax your way. It customizes massages from sports recovery techniques to Tai Tai, hour-glass beauty massage and a throne massage especially designed for CEOs or people from white collar jobs to unwind and destress their body. uInfinity has everything to become your essential lifestyle partner. It’s

“Performance of the BFSI sector is the barometer of the economy”- Deputy Governor, RBI, SS Mundra at ET BFSI Leadership Exchange Summit 2017

Mumbai, june 28, 2017: The Economic Times BFSI Leadership Exchange Summit 2017 held at The Leela, Mumbai, saw luminaries from the banking, financial services and insurance sector from India, UAE and Middle East discussing various aspects to bring in a paradigm shift in the way the BFSI sector will function in the future. The summit came into being to create a platform for global leaders to increase opportunities within the banking, financial services and insurance sector.The summit commenced with a panel discussion on the talent continuum; integrating HR with business strategies, which helped

Sanofi and Regeneron Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union

Paris, June 28, 2017: Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the European Commission (EC) has granted marketing authorization for Kevzara® (sarilumab) in combination with methotrexate (MTX) for the treatment of moderately to severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to – or who are intolerant to – one or more disease modifying anti-rheumatic drugs (DMARDs), such as MTX.1 Kevzara may be used as monotherapy in case of intolerance to MTX or when treatment with methotrexate is inappropriate.1 Kevzara is a human monocl

Takeda and BE Collaborate to Develop Low-Cost Vaccines for Low and Middle-Income Countries

Two recently-signed agreements will transfer Takeda's measles and acellular pertussis vaccine technologies to India-based multi-national company Biological E. Limited (BE) to develop low-cost combination vaccines including diphtheria, tetanus and acellular pertussis (DTaP) and measles-rubella (MR) vaccines Hyderabad, June 28, 2017: Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") and Biological E. Limited (BE) today announced that they have entered into a collaboration whereby two licensing agreements to expedite the development and delivery of affordable combination vaccines ha

Parry Nutraceuticals and Synthite Industries Forge Partnership for Extraction of Phycocyanin

Chennai, June 23, 2017: Parry Nutraceuticals (a division of EID Parry and part of the Murugappa Group) has forged a partnership with Synthite Industries, to apply proprietary patented technologies for extraction of Phycocyanin, a natural blue pigment found in Spirulina. Natural Blue is one of the Primary colours, which is difficult to master and has very limited sources that are acceptable by regulatory bodies. Phycocyanin (Extracted from Spirulina) is approved by all major regulatory bodies in USA, EU, Japan and South Korea as food colour. Moreover Phycocyanin offers excellent stability and

Asia Pacific Nutraceuticals Market Outlook to 2021: Ken Research

New Delhi, June 23, 2017: The report titled “ Asia Pacific Nutraceuticals Market Outlook 2021 – Extensive Customer Base Coupled with Rising Disposable Income in India and China to Foster Growth ” provides a comprehensive analysis of nutraceuticals market in Asia-Pacific region. The report focuses on overall market size for Asia Pacific nutraceuticals market, market segmentation on the basis of Dietary Supplements, Functional Foods and Beverages, sub-segmentation's on the basis of Dietary Supplements by Type of Supplements, Functional Foods and Beverages by Food Category and market se

Lupin launches generic Topicort® LP Emollient Cream and Topicort® Cream in the US

Mumbai, June 22, 2017: Pharma Major Lupin Limited (Lupin) announced today the launch of its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% having received an approval from the United States Food and Drug Administration (FDA) earlier. Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% are the AB rated generic equivalent of Taro Pharmaceuticals North America, Inc’s Topicort® LP Emollient Cream, 0.05% and Taro Pharmaceuticals, Inc’s (collectively Taro) Topicort® Cream, 0.25%. Both products are indicated for the relief of the inflammatory and pruritic m

Akshar Yoga ushers in International Yoga Day 2017 with a minute long Sirshasana (headstand)

Events conducted across more than six countries Bengaluru, June 22, 2017: On this International Yoga Day (IYD), Akshar Yoga hosted a grand yoga session with a 1 minute Sirshasana (headstand) performed by a group of 500 yogis at the rooftop of World Trade Centre, Bangalore. Yoga enthusiasts from different parts of the globe, came together to participate in this memorable moment with Grandmaster Akshar, internationally acclaimed Yogic master and Founder, Akshar Yoga. Akshar Yoga trainers travelled to 120 locations globally on this day to perform yoga sessions in Mumbai, Lucknow, Delhi, United S

Varian Works with Sify Technologies to Host Data Remotely Across CTSI Network of Cancer Centers in India

Hyderabad, June 22, 2017: In the first project of its kind outside the United States, Varian Medical Systems (NYSE: VAR) is working with Sify Technologies to provide software-as-a-service (SaaS) to radiotherapy centers across India. The innovative service, which hosts oncology information and treatment planning software in the cloud and allows clinical teams to focus on treating patients, is being implemented as part of a multi-million dollar investment in treatment equipment and software across Cancer Treatment Services International CTSI's network of cancer hospitals in India and South Asi

Breathe Fresh and Live Fresh with Auzair Fresh Air Bottles

New Delhi, June 22, 2017: The recent technological advancement has degraded the living conditions by polluting the natural resources. The life has become faster and easier but shorter and painful. There have been a number of researches made on the potential long-term effects of living in a polluted location. These researchers are focusing on the effects such as cardiovascular illness, loss of lung function, damage to cells in the body and a shortened life span just to name a few. There is an immediate need to control the declining living conditions around us but not at the dampening of technol

Glenmark Pharmaceuticals Licences Small Molecule Oncology Compound from APC Therapeutics

Mumbai, June 22, 2017: Pharma Major Glenmark Pharmaceuticals today said that company has entered into a licencing agreement with the Boston-based APC Therapeutics Inc. APC Therapeutics Inc is a biopharmaceutical company focused on building a portfolio of best-in-class immuno-oncology (IO) therapies, for exclusive rights to a small molecule, oncology compound based on Antigen Presenting Cell (APC) biology, company release said.United News of India

Lupin appoints Pooja Thakran as Head Corporate Communications

Mumbai, June 22, 2017: Pharma major Lupin Limited (Lupin) today announced the appointment of Pooja Thakran as Head-Corporate Communications. Pooja will lead the Corporate Communications function for Lupin globally and will be based at the company’s corporate headquarters in Mumbai, India. Pooja comes to Lupin with over 22 years of experience across diverse corporate backgrounds Telenor, Alstom Grid, Aon Hewitt, GE Capital, HP India, ITC Sheraton Hotels and Taj Hotels. Commenting on the appointment, Mr Nilesh Gupta, Managing Director, Lupin Limited said, 'We are very happy to have Pooja join

Upcoming Events
National 'Arogya Fair' 2017

National 'Arogya Fair' 2017... PHD Chamber of Commerce and In

Vascular Biology 2017

Vascular Biology 2017... The committee of International

Clinical Trials 2017

Clinical Trials 2017... 4th International Conference o

Metabolomics Conference 2017

Metabolomics Conference 2017... “9th International Conferen

Nucleic Acids 2017

Nucleic Acids 2017... We are pleased to invite the c

Biosimilars Asia 2017

Biosimilars Asia 2017... 8th Asian Biosimilars Congre

Pharmacognosy 2017

Pharmacognosy 2017... Conference Series LLC invites

Heart Diseases 2017

Heart Diseases 2017... The Annual Conference on Heart

19th Euro Cancer Science and Therapy Congress

19th Euro Cancer Science and Therapy Congress... Conference Series LLC extends

Structural Biology 2017

Structural Biology 2017... Conference Series LLC welcome

Clinical Research 2017

Clinical Research 2017... Clinical Research 2017 Confere

Pharmaceutical and Biomedical Engineering 2017

Pharmaceutical and Biomedical Engineering 201... ConferenceSeries Ltd is a reno

International Conference on Enzymology 2017

International Conference on Enzymology 2017... INTERNATIONAL CONFERENCE ON EN

20th MedExpo Tanzania 2017

20th MedExpo Tanzania 2017... The 19th MEDEXPO 2017 - Intern

5th International Conference and Exhibition on Pharmacology & Ethnopharmacology

5th International Conference and Exhibition o... Conference Series LLC invites

Cardiac Pharmacology 2017

Cardiac Pharmacology 2017... Conference Series LLC is a ren

Error
  • Cannot retrive forecast data in module "mod_sp_weather".

National

Re-development/ expansion of various departments/ services o...
Rss  
Here is a need to inNew Delhi, September 25, 2013: The President
Ranbaxy Delivers Str Q3 CY 2012 Sales Rs.26,514 Mn ($480 Mn), EB
Revised lower price  The court said the drug firms should implem
Dr.Manmohan Singh toJammu February 3, 2014: The 101th session of
Sun Pharma to Acquir Wilmington, MA and Mumbai, India November 0

Press Release

65th Annual National Conference of the Indian Psychiatric So...
Rss  
Ex-Lupin honcho becoMumbai, April 2,2014 - Satish Khanna , form
Actavis PharmaceuticNew Actavis / Bioton alliance to shake up dia
PHFI Study HighlightNew Delhi , June 13, 2014 - Key findings from
ClearPath RevolutionNew Delhi February 18, 2014: ClearPath Ortho
Pharma Spectrum 201Mumbai December 20, 2013:  Based on the rece

International

PAT before Exceptional Items Grows 7.4% in Fourth Quarter of...
Rss  
Health tops new NestMumbai, April 02,2014 - The attention in the
Former CEC, Dr. S. YMumbai, Maharashtra, India, Thursday, March 2
Elder Pharma to focuNew Delhi December 27, 2013: After selling it
GlaxoSmithKline PharGlaxoSmithKline Pharmaceuticals Limited has a
International medicaNew Delhi, March 13,2014: More than 450 exhib

Awards

At AstraZeneca, we recognize that advances in medicine rely ...
Rss  
Arogya World RecogniBangalore, Karnataka, India, Wednesday, Novem
Dr. B R Shetty HonouDubai, July 10, 2014 - Dr. B R Shetty is the
Nominated for Pharma Upinder Zutshi Of Infinite Computers to make
Cambridge varsity hoMUMBAI, July 05, 2014 : Yusuf Khwaja Hamied,
Mir Lifescience winsKochi March 8, 2014 : Mir Lifescience, a divi
Category: Company News
Print


New Delhi, July 05, 2014 - Arecent McKinsey report states that Indian pharmaceutical market can reach USD 55 billion by 2020, and the market has also the potential to touch USD 70 billion, but it comes with a rider. To achieve this target, the industry should putconcerted efforts in the five key emerging opportunities namely, patented products, consumer healthcare drugs, biologics, vaccines, and the public health market.The same report also cautions that pricing control and economic slowdown may lead to a downturn in the market, to USD 35 billion.

While the external factors get difficult to control, the pharmaceutical companies need to strengthen the internal operational capabilities, in order to grow profitably. The rising industry complexity is a factor thatcompels the industry players to boost collaboration among the stakeholders and strive to sustain the performance. The major challenges that are impacting the business prospects for Indian pharmaceutical companies include quality of drugs, quality of clinical trials, and patent issues.Recently, some Indian pharmaceutical companies have been penalized in the USA for flouting FDA norms.

Cost leadership is a major differentiator for market competitiveness. Large pharmaceutical companies are normally adopting various strategic business initiatives such as ERP, Six Sigma, Lean, TQM, TPM, and contemporary management accounting techniques to optimize productivity and cost of the product. As business complexity in pharmaceutical sector is a given, it is an imperative for the pharmaceutical companies to adopt technology solutions to increase the operational excellence. With advanced technology solutions, the pharmaceutical companies can improve the visibility of data across the business processes and can take faster business decisions.

Inherent Challenges in Life Sciences Industry

Missing Operational Excellence

Pharmaceutical companies should strive foroperational excellence to thwart market competition. To achieve operational excellence, the pharmaceutical companies should focus on better quality, industry compliance, increased productivity, higher throughput, low utility cost, and less waste.However, the small and medium enterprises (SMEs) are reluctant to invest in technology. Lower technology investment restricts the operational efficiency of the company and increases the operational cost.

Lack of Data-driven Decisions

Since pharmaceutical industry is highly scientific process oriented, it is necessary for the companies to explore data-driven decision making. According to a Thompson Reuters report, 26.5% IT leaders catering to the IT needs of pharmaceutical industry predict that “big data” will play a major role in the decision making process.There is an urgent need to exploit“big data”to derive useful insights for better planning and decision-making. Unfortunately, the Indianpharmaceutical industry is slow to catch up with this technological trend.

Inefficient Supply Chain

Supply chain is the backbone of pharmaceutical industry. From drug discovery to clinical trials, to manufacturing, to distribution, each segment requires a robust supply chain management process to increase productivity and operational inefficiency. According to a report, an efficient supply chain management can reduce inventory holding by 25%-60% and improve the order fulfillment cycle time by 30%-50%. But the inability of developing an efficient supply chain costs the companies heavily. For example, poor inventory planning can cost a pharmaceutical company 10%-18% of net revenues.

Stringent Regulatory Control

There is an increasing need for compliance with regulatory norms of different countries and international agencies such as FDAand WHO. If a company wishes to market the products in the US region, an approval from FDA is mandatory. The clinical trial process also attracts major attention from the FDA regarding safety, efficacy, capacity, and purity of the drug. The pharmaceutical companies are also subject to various state and federal laws regarding production environment, safety, and environment protection.

Poor Drug Quality

Quality is a major issue with pharmaceutical manufacturers. In 2013, a major Indian pharmaceutical company was penalized in the US for flouting the FDA quality norms.There are many instances when Indian regulators collude with local manufacturers to approve the products. This allows smaller companies to manufacture sub-standard drugs and market it in the developing countries.The sub-standard drugs available at lower price pose a threat to the quality drugs marketed by leading pharmaceutical companies.

Leveraging the Technology to Optimize Growth Opportunities

What’s required for Indian life sciences companies today to mitigate the daunting challenges is, to adopt technology solutions. For example, Tectura® Life Sciences solution, built on Microsoft Dynamics, covers all business areas: from purchasing, sales, production, financial accounting, quality control, vendor rating, raw material data management, laboratory systems, resource management, warehouse management, and logistics, to marketing and distribution. Many leading life sciences companies of India have leveraged this solution to improve their operational efficiency.Life sciences companies require customized solution to address their challenges.For example, order management, formulation,active ingredients administration, inventory management, lot tracing, sequence planning, quality management, supply chain management, and production planning are the key areas to be integrated.

Bringing in Manufacturing Excellence

Companies need a solution having greater flexibility, easy integration, and extensive features to support the business operations. Components like manufacturing specification provide data to core ERP solution through an interface, which is version controlled and user authenticated. Similarly, formulae,BOMs, and recipes are critical data structures that life sciences companies adhere to strictly. Tectura Life Sciences offers extensive functionalities to configure manufacturing specifications, recipes, formula’s bills of materials (BOMs), and work plans. The manufacturing specifications can be integrated with Microsoft Dynamics solution. It helps compiling all necessary work instructions basis the production plan. Being version controlled and protected by password, this module ensures that data security is maintained.

Conforming to Regulatory Compliances

As life sciences companies need to meet the FDA/GMP/WHO compliances, there is an urgent requirement for the companies to look for a comprehensive solution that can help reduce the risk of non-compliance along with complete visibility into the quality of products. Tectura Life Sciences solution allows companies to ensure adhering to FDA regulations, complying with standard operating procedures, and validating the industry checklists.This solution is compliant with GMP requirements, and maintains audit trails and signature records for both manual and automated transactions to satisfy 21 CFR Part 11.

Ensuring Better Quality of Products

In life sciences industry, quality management acts as an ethical guide to deliver the product as promised to customers. The industry has a mandate to comply with a number of regulatory compliances, which again largely address to the quality of the product. Tectura Quality Management solution offers a wide range of measures such as test plans, process tests, test orders, test accuracy control, skip-lot function, and vendor rating to thwart the challenges. The solution also provides components to integrate client-defined measures to abide by the quality policies of the company. Companies can easily integrate all test areas with procedural documents to ensure easy validation.

Faster Product Recall

Lot tracing is a critical component for life sciences operational process. For instance, during FDA audits if any product fails to meet the standards, then the company should recall the product immediately. Tectura's Life Sciences solution enables complete lot and serial traceability with forward and backward tracking capability across the production chain. This feature improves the response time for product recall and ensures peace of mind for the manufacturers.

Efficient Production Planning

During production planning and control stage, life sciences companies need planning functionalities that allow optimal resource utilization. Companies require integrated sequence planning to configure planning parameters, schedules, resource availability, and sequencing. Mostly, at production floor short-term changes are expected due to machine failures and unplanned customer orders. The production manager should ensure that resource utilization is optimized and transparency is built into the system. With advance sequence planning module of Tectura Life Sciences, companies can even handle ad hoc requirements more efficiently without disturbing the scheduled jobs. During scheduling and sequence optimization, the production floor manager can verify inventory to check whether the required materials are available in the stock and right measures are predefined in the system.

Managing Cost Optimally

As life sciences companies use myriads of raw materials to compose a complex molecule, calculating the costing of individual ingredients is necessary. While many ERP solutions have inherent issues in calculating the cost of a product, Tectura Life Sciences solution helps calculate the production cost basis the raw material price and the amount of portion used. Various fixed and variable costs are defined to estimate the final cost of the finished product. Using this solution, companies can define the size of lots and relationship between quantity and unit cost.

Conclusion

As the Indian life sciences industry is faces global competition, itiscrucial for the business owners and decision makers of the company to rely on comprehensive business solutions to mitigate the daunting challenges. Many leading pharmaceutical companies have trusted innovative business solutions like Tectura Life Sciencessolution that integrates all business processes, including production and planning, quality, supply chain, sales and marketing, and finance and accounting. It allows companies to bring in operational excellence,conform to quality and regulatory compliance,and increase profitability.

About the Author

Mr. Chetan Pathak, Corporate Operations Director, Tectura India

Managing at the helm of Tectura India, Chetan exemplifies Tectura’s commitment to delivering exceptional and sustained value to the clients. Chetan joined Tectura India as Corporate Operations Director in April 2009. With an extensive and diverse experience of over 26 years in the areas of technology and consulting business, Chetan spearheads Tectura’s strategy for operations in India, Nepal, Bangladesh, Sri Lanka, Maldives, Mauritius, and New Caledonia. Chetan is Tectura India’s primary decision- and policy-maker, setting the tone for company’s values, ethics, and culture.

In this capacity, Chetan provides complete leadership on strategic and operational issues. A proven leader with deep expertise in executing on strategic global, regional, and local initiatives and goals, Chetan manages growth of Tectura India’s business, profitability, and customer satisfaction. With a passion for mentoring and coaching, Chetan builds up the path for enterprise leadership team. At Tectura India, he drives three revenue streams – Local Business, Direct Offshoring, and Inter-company Business. Chetan leads relationship management with Microsoft and various channel partners. His focus for business excellence has helped Tectura India achieve many awards from Microsoft locally and globally.

Prior to joining Tectura India, Chetan was the Vice President – India Operations, Ramco Systems. At Ramco Systems, he was responsible for managing the Enterprise Solutions business, Enterprise Process Solutions business, SaaS business, and BPO. Before joining Ramco Systems, Chetan also worked with leading technology organizations such as Tata Unisys and IDM Ltd. Chetan holds a BE degree in Mechanical Engineering and MBA in Marketing Management from Gujrat University. CCI Newswire

Email address:


Classifieds

The Pharma Times News Portal

 The Pharma Times The Pharma Times portal provides pharmacists, pharmacy technicians, and others i

Read more

Weather

Exclusive on Pharma Times

Mumbai, May 22, 2014 - The Bhabha A

New Delhi December 18, 2013: There

Africa November 7,2013: The Union

Daily Updates -International

Daily Updates - National

  • 1
  • 2
Prev Next
Omron Blood Pressure Monitor, HEM-7113
Automatic Capsule Filling Machine (PF-150)
Gelusil liquid antacid - Pfizer’s
The Varilux 3.0 range lenses - Essilor
Blossom Kochhar Aroma Magic Anti Pigmentation Serum
 The Property Times